GOLD stage 0 and risk of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003
The prevalence of QTc-prolongation increase by GOLD stage in COPD Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017
Impact of symptomatology in patients with GOLD stage I COPD Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010
GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Physician-diagnosed COPD GOLD stage IV in Östersund, Sweden: prevalence and patient characteristics Source: Eur Respir J 2006; 28: Suppl. 50, 447s Year: 2006
Impact of comorbidities on survival of patients with COPD according to GOLD stages Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011
Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005
Prevalence and severity of GOLD defined COPD in adults Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002
High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013
Copeptin and GOLD stage are independent predictors of exertional desaturation in patients with COPD Source: Annual Congress 2010 - Research development in exercise and gas exchange Year: 2010
Prevalence of co-morbidities in Greek COPD patients in relation to the stage of the disease (COMPACT study) Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017
COPD GOLD stage 1: Is it really a disease? Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017
The effect of changing GOLD severity stage on long-term mortality in COPD Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017
GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Validation of non-spirometric predictors of COPD to the GOLD stage classification Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002
Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003
Comorbidities in stage IV COPD patients Source: Annual Congress 2011 - COPD management Year: 2011
Sarcopenia in Japanese patients with COPD: prevalence, relationship with COPD severity. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
Ventilation-perfusion imbalance and GOLD stages in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 407s Year: 2006